Improved fertility diagnostics could boost bird conservation breeding programmes, say scientists
A new analytical method is revealing how conservationists can further boost breeding programmes dedicated to saving some of the world’s most threatened species, according to new research led by the University of Sheffield and ZSL.
Reducing the environmental ‘paw-print’ - plant-based dog foods are better for the environment than red meat options
A new study, led by experts at the University of Nottingham, has found that the production of meat-based pet foods has a much greater impact on the environment in comparison to plant-based alternatives.
World Rabies Day: Charity puts out call for volunteers who want to help make rabies history
Every year on the 28th of September, World Rabies Day aims to raise awareness of rabies and advocate for the global elimination of the disease. The date honours Louis Pasteur, who produced the first anti-rabies vaccine in 1885. Despite an effective vaccine being developed 140 years ago, rabies still causes suffering and death for both people and animals in most of the world. Each year over 59,000 people die from rabies, children under 15 years of age are particularly vulnerable, accounting for forty percent of global deaths. According to World Health Organisation, over 99 percent of all human rabies cases are transmitted via dog bites.
Empowering the Next Generation of Veterinary Heroes: The Halo House Veterinary Scholarship Fund
The Halo House is proud to support the future of veterinary medicine while amplifying the lifesaving work of PETA through its new Veterinary Scholarship Fund. In partnership with PETA, this initiative gives aspiring veterinarians and veterinary technicians a chance to advance their careers while helping to end animal homelessness and provide care to underserved communities.
MSD Animal Health Launches NUMELVI® (atinvicitinib) Tablets for Dogs – A Veterinary Innovation in Fast, Effective and Safe Targeted Itch Relief
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission (EC) has approved NUMELVI™ (atinvicitinib) Tablets for Dogs.
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling"

